Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat

Neurobiology of Disease

Volumn 43, Issue 3, 2011, Pages 552-557

  Kordower, Jeffrey H ^a   Dodiya, Hemraj B ^a   Kordower, Adam M ^a   Terpstra, Brian ^b   Paumier, Katrina ^b   Madhavan, Lalitha ^b   Sortwell, Caryl ^b   Steece Collier, Kathy ^b   Collier, Timothy J ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Alpha synuclein; Dopamine; Prion; Transplants

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SYNUCLEIN; GREEN FLUORESCENT PROTEIN; OXIDOPAMINE; PROTEINASE K; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEWY BODY; MALE; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN TRANSPORT; RAT;

ALPHA-SYNUCLEIN; ANIMALS; DOPAMINE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; LEWY BODIES; MALE; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, INBRED F344; SYMPATHOLYTICS;

EID: 79960285197     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.05.001     Document Type: Article

References (21)

1. Angot E., Steiner J.A., Hansen C., Li J.Y., Brundin P. Are synucleinopathies prion-like disorders?. Lancet Neurol. 2010, 9:1128-1138.
2. Braak H., de Vos R.A., Bohl J., Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 2006, 396:67-72.
3. Brundin P., Li J.Y., Holton J.L., Lindvall O., Revesz T. Research in motion: the enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 2008, 9:741-745.
4. Brundin P., Melki R., Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 2010, 11:301-307.
5. Chu Y., Kordower J.H. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?. Neurobiol. Dis. 2007, 25:134-149.
6. Chu Y., Kordower J.H. Lewy body pathology in fetal grafts. Ann. N. Y. Acad. Sci. 2010, 1184:55-67.
7. Chu Y., Dodiya H., Aebischer P., Olanow C.W., Kordower J.H. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol. Dis. 2009, 35:385-398.
8. Cooper O., Astradsson A., Hallett P., Robertson H., Mendez I., Isacson O. Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients. J Neurol. 2009, 256(Suppl 3):310-316.
9. Desplats P., Lee H.J., Bae E.J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13010-13015.
10. Duda J.E., Giasson B.I., Mabon M.E., Lee V.M., Trojanowski J.Q. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann. Neurol. 2002, 52:205-210.
11. Gundersen H.J., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 1987, 147:229-263.
12. Hansen C., Angot E., Bergstrom A.L., Steiner J.A., Pieri L., Paul G., Outeiro T.F., Melki R., Kallunki P., Fog K., Li J.Y., Brundin P. Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest. 2011, 121:715-725.
13. Jakes R., Crowther R.A., Lee V.M., Trojanowski J.Q., Iwatsubo T., Goedert M. Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. Neurosci. Lett. 1999, 269:13-16.
14. Kordower J.H., Chen E.Y., Sladek J.R., Mufson E.J. trk-immunoreactivity in the monkey central nervous system: forebrain. J. Comp. Neurol. 1994, 349:20-35.
15. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14:504-506.
16. Kordower J.H., Chu Y., Hauser R.A., Olanow C.W., Freeman T.B. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov. Disord. 2008, 23:2303-2306.
17. Lee H.J., Patel S., Lee S.J. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 2005, 25:6016-6024.
18. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bjorklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14:501-503.
19. Li J.Y., Englund E., Widner H., Rehncrona S., Bjorklund A., Lindvall O., Brundin P. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov. Disord. 2010, 25:1091-1096.
20. Steece-Collier K., Soderstrom K.E., Collier T.J., Sortwell C.E., Maries-Lad E. Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in Parkinsonian rats. J. Comp. Neurol. 2009, 515:15-30.
21. West M.J. New stereological methods for counting neurons. Neurobiol. Aging 1993, 14:275-285.